Status:

COMPLETED

Biobased Polyester Versus Synthetic Fiberglass Casts for Treating Stable Upper Limb Fractures in Children

Lead Sponsor:

Far Eastern Memorial Hospital

Conditions:

Upper Limb Fracture

Eligibility:

All Genders

4-18 years

Phase:

NA

Brief Summary

From Feb 2022 to Nov 2022, we undertook a single-center prospective randomized trial involving 100 children with cast-immobilized stable upper limb fractures. These patients were randomized into eithe...

Detailed Description

The clinical trial was approved by the research ethics review committee of the author's hospital and informed consent was obtained from the legal guardian of each patient. Between Feb 2022 and Nov 202...

Eligibility Criteria

Inclusion

  • stable upper limb fractures (including radius, ulna, and distal humerus fractures such as Garland type I supracondylar fractures of the humerus) diagnosed at the orthopedic outpatient clinic or emergency room of a tertiary trauma center hospital

Exclusion

  • displaced or unstable fractures indicated for close or open reduction and fixation
  • previous surgeries to the affected upper limb
  • history of any chronic skin pathology (e.g., atopic dermatitis)
  • known allergy to cast materials

Key Trial Info

Start Date :

January 27 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 28 2022

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT06102603

Start Date

January 27 2022

End Date

September 28 2022

Last Update

October 30 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Far Eastern Memorial Hospital

New Taipei City, Taiwan, 220

Biobased Polyester Versus Synthetic Fiberglass Casts for Treating Stable Upper Limb Fractures in Children | DecenTrialz